TYMS Antikörper
Kurzübersicht für TYMS Antikörper (ABIN2745139)
Target
Alle TYMS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Human TS / Thymidylate Synthase
-
Aufreinigung
- Protein G purified
-
Immunogen
-
Recombinant human Thymidylate Synthase.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Approved: ELISA, Flo (0.5 - 1 μg/10 x106), IF (0.5 - 1 μg/mL), IHC, IHC-P (0.5 - 1 μg/mL), IP, WB (0.25 - 0.5 μg/mL)
Usage: This antibody is specific for a protein of 36 kDa, identified as Thymidylate Synthase (TS). Thymidylate synthase converts deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), which is essential for DNA biosynthesis. Thymidylate synthase is also a critical target for the fluoropyrimidines, an important group of anti-neoplastic drugs that are widely used in the treatment of solid tumors. Both 5-FU and fluorodeoxyuridine are converted in tumor cells to FdUMP which inactivates thymidylate synthase by formation of a ternary covalent complex in the presence of the folate cofactor 5,10-methylenetetrahydrofolate. Expression of thymidylate synthase protein is associated with response to 5-fluorouracil (5-FU) in human colorectal, gastric, head and neck, and breast carcinomas. ELISA: Order BSA-free antibody format for coating. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.1 mg/mL BSA, 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2°C to 8°C.
-
-
- TYMS (Thymidylate Synthetase (TYMS))
-
Andere Bezeichnung
- TS / Thymidylate Synthase
-
Hintergrund
-
Name/Gene ID: TYMS
Synonyms: TYMS, HST422, Thymidylate synthetase, TMS, TS, Thymidylate synthase, Tsase -
Gen-ID
- 7298
-
Pathways
- Mitotic G1-G1/S Phases
Target
-